Combination of Calcipotriene Foam, 0.005% and Tazarotene Foam, 0.1% in the Treatment of Plaque Psoriasis of the Scalp and Body: A Case Report

Main Article Content

Hee J Kim
Mark G Lebwohl


psoriasis, topical, calcipotriene, tazarotene


Abstract not available.


Disclosures: Study sponsored by Mayne Pharma.


Copyright SKIN 2018

Most read articles by the same author(s)